A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine

NCT05238454 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Infection

Interventions

BIOLOGICAL: SCTV01C
BIOLOGICAL: Sinopharm inactivated COVID-19 vaccine
BIOLOGICAL: Comirnaty

Sponsor

Sinocelltech Ltd.